PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
149.60%
Cash & equivalents changing by 149.60% while Healthcare maintains stable levels. Benjamin Graham would examine if this divergence is justified.
No Data
No Data available this quarter, please select a different quarter.
149.60%
Cash + STI yoy growth ≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt would see a liquidity advantage if effectively redeployed.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
133.42%
Current assets growth ≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees a potential liquidity edge if well allocated.
835.01%
PP&E growth ≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees aggressive expansion. Check if revenue growth supports it.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1079.37%
≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees more aggressive long-term asset growth than peers, but it must be value-accretive.
No Data
No Data available this quarter, please select a different quarter.
135.47%
≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees more aggressive asset expansion than peers, but must confirm returns are adequate.
69.91%
Payables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a warning sign of stressed supplier payments.
-41.82%
Above 1.5x Healthcare median of 0.00%. Jim Chanos might see a short-term leverage spike, raising red flags for near-term solvency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-49.13%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a potential short-term burden spike.
-44.50%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects potential working capital strain.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-44.50%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects an alarming rise in overall leverage.
7.98%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects heavier share issuance than peers.
4.22%
≥ 1.5x Healthcare median of 0.00%. Joel Greenblatt sees stronger retained profit growth vs. peers.
-271.57%
Above 1.5x Healthcare median 0.00%. Jim Chanos suspects a red flag if these gains are highly volatile.
No Data
No Data available this quarter, please select a different quarter.
132.15%
≥ 1.5x Healthcare median of 0.00%. Joel Greenblatt sees stronger equity growth vs. peers.
135.47%
≥ 1.5x Healthcare median of 0.00%. Joel Greenblatt sees more aggressive expansions than peers.
No Data
No Data available this quarter, please select a different quarter.
-41.82%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a big rise in leverage. Check coverage carefully.
-152.72%
Above 1.5x Healthcare median 0.00%. Jim Chanos sees a big jump in net debt. Potential leverage red flag.